Advisory Services Network’s Clearside Biomedical CLSD Stock Holding History

Advisory Services Network’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-47	Closed	-$1K	–	3102
2019 Q3	$1K	Hold	47	–	–	﹤0.01%	2696
2019 Q2	$1K	Buy	+47	New	+$838	﹤0.01%	2694

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Advisory Services Network's CLSD Position: Q4 2019 in Review

Advisory Services Network sold out of Clearside Biomedical (CLSD) in Q4 2019, closing a stake of 47 shares — an estimated $1K sold.

Advisory Services Network first reported a position in CLSD in Q2 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 47 funds tracked by Wall St. Rank hold CLSD as of Q4 2019.

Advisory Services Network reported no remaining Clearside Biomedical position as of Q4 2019 after selling out during the quarter.
Advisory Services Network sold 47 Clearside Biomedical shares in Q4 2019, an estimated $1K.
Advisory Services Network first reported a position in Clearside Biomedical in Q2 2019 and held it in 2 quarters.
Advisory Services Network's Clearside Biomedical position peaked at $1K in Q3 2019.
47 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2019.

Based on Advisory Services Network's 13F filing for Q4 2019, filed 4 Feb 2020.